{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:40:06Z","timestamp":1741754406298,"version":"3.38.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K14953"],"award-info":[{"award-number":["JP18K14953"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bcp.2024.116514","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:05:45Z","timestamp":1725379545000},"page":"116514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of human-specific amino acid residues governing atenolol transport via organic cation transporter 2"],"prefix":"10.1016","volume":"229","author":[{"given":"Akira","family":"Hosooka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Yasujima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayano","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116514_b0005","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2024.116514_b0010","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425255.2.4.505","article-title":"Drug-drug interactions involving membrane transporters in the human kidney","volume":"2","author":"Li","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bcp.2024.116514_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2024.116514_b0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.apsb.2016.07.013","article-title":"Renal drug transporters and their significance in drug-drug interactions","volume":"6","author":"Yin","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2024.116514_b0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1152\/physrev.00040.2003","article-title":"Molecular and cellular physiology of renal organic cation and anion transport","volume":"84","author":"Wright","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2024.116514_b0030","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2024.116514_b0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The SLC22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"Koepsell","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bcp.2024.116514_b0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1208\/s12248-013-9460-z","article-title":"Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects","volume":"15","author":"Yoon","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.bcp.2024.116514_b0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1124\/jpet.111.184986","article-title":"Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney","volume":"340","author":"Ito","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2024.116514_b0050","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0090-9556(25)06742-X","article-title":"Species similarities and differences in pharmacokinetics","volume":"23","author":"Lin","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2024.116514_b0055","first-page":"F450","article-title":"Peritubular organic cation transport in isolated rabbit proximal tubules","volume":"266","author":"Groves","year":"1994","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.bcp.2024.116514_b0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00373751","volume":"419","author":"Ullrich","year":"1991","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bcp.2024.116514_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101974","article-title":"Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1","volume":"298","author":"Meyer","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116514_b0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cpt1976205524","article-title":"Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker","volume":"20","author":"Brown","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2024.116514_b0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cpt1979254408","article-title":"Kinetics and absolute bioavailability of atenolol","volume":"25","author":"Mason","year":"1979","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2024.116514_b0080","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1124\/dmd.115.066175","article-title":"Atenolol renal secretion is mediated by human organic cation transporter 2 and multidrug and toxin extrusion proteins","volume":"43","author":"Yin","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2024.116514_b0085","doi-asserted-by":"crossref","first-page":"18105","DOI":"10.1038\/s41598-019-54367-9","article-title":"Identification of the amino acid residue responsible for the myricetin sensitivity of human proton-coupled folate transporter","volume":"9","author":"Yamashiro","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116514_b0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/dmd.109.030221","article-title":"Evaluation of 4',6-diamidino-2-phenylindole as a fluorescent probe substrate for rapid assays of the functionality of human multidrug and toxin extrusion proteins","volume":"38","author":"Yasujima","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2024.116514_b0095","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.xphs.2020.04.013","article-title":"Functional analysis of the role of equilibrative nucleobase transporter 1 (ENBT1\/SLC43A3) in adenine transport in HepG2 cells","volume":"109","author":"Takenaka","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2024.116514_b0100","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201629","article-title":"Disrupted in renal carcinoma 2 (DIRC2\/SLC49A4) is an H(+)-driven lysosomal pyridoxine exporter","volume":"6","author":"Akino","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.bcp.2024.116514_b0105","first-page":"166","article-title":"Functional identification of organic cation transporter 1 as an atenolol transporter sensitive to flavonoids","volume":"2","author":"Mimura","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bcp.2024.116514_b0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0047-6374(93)90123-9","article-title":"Stereoselective pharmacokinetics of atenolol in the rat: influence of aging and of renal failure","volume":"67","author":"Belpaire","year":"1993","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bcp.2024.116514_b0115","doi-asserted-by":"crossref","first-page":"F679","DOI":"10.1152\/ajprenal.2000.279.4.F679","article-title":"Localization of organic cation transporters OCT1 and OCT2 in rat kidney","volume":"279","author":"Karbach","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bcp.2024.116514_b0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/372549a0","article-title":"Drug excretion mediated by a new prototype of polyspecific transporter","volume":"372","author":"Grundemann","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116514_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186627","article-title":"The impact of genetic polymorphisms in organic cation transporters on renal drug disposition","volume":"21","author":"Zazuli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116514_b0130","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41594-023-01017-4","article-title":"Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2","volume":"30","author":"Suo","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2024.116514_b0135","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2024.116514_b0140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116514_b0145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.113.203257","article-title":"Substrate-dependent ligand inhibition of the human organic cation transporter OCT2","volume":"346","author":"Belzer","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2024.116514_b0150","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1021\/mp400113d","article-title":"Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+","volume":"10","author":"Thevenod","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2024.116514_b0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/jpet.121.000619","article-title":"Cationic compounds with SARS-CoV-2 antiviral activity and their interaction with organic cation transporter\/multidrug and toxin extruder secretory transporters","volume":"379","author":"Martinez-Guerrero","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2024.116514_b0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00008571-200207000-00007","article-title":"Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function","volume":"12","author":"Leabman","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bcp.2024.116514_b0165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/dmd.106.013581","article-title":"Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population","volume":"35","author":"Kang","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2024.116514_b0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jps.20536","article-title":"Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants","volume":"95","author":"Fujita","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2024.116514_b0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1165\/rcmb.2004-0363OC","article-title":"Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium","volume":"33","author":"Lips","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bcp.2024.116514_b0180","doi-asserted-by":"crossref","first-page":"C1521","DOI":"10.1152\/ajpcell.00622.2005","article-title":"Characterization of regulatory mechanisms and states of human organic cation transporter 2","volume":"290","author":"Biermann","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bcp.2024.116514_b0185","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00210-007-0219-x","article-title":"Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1)","volume":"376","author":"Nies","year":"2008","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116514_b0190","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1124\/mol.117.111443","article-title":"Assessment of substrate-dependent ligand interactions at the organic cation transporter OCT2 using six model substrates","volume":"94","author":"Sandoval","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116514_b0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/jpet.105.088104","article-title":"A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters","volume":"315","author":"Tahara","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2024.116514_b0200","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2014.66","article-title":"Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat","volume":"86","author":"Lepist","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2024.116514_b0205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.54.2.342","article-title":"Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine","volume":"54","author":"Busch","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116514_b0210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/FPC.0b013e32832cc7e9","article-title":"Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin","volume":"19","author":"Chen","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.bcp.2024.116514_b0215","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1007\/s11095-015-1675-5","article-title":"Unstirred water layers and the kinetics of organic cation transport","volume":"32","author":"Shibayama","year":"2015","journal-title":"Pharm. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224004970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:17:19Z","timestamp":1741713439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224004970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":43,"alternative-id":["S0006295224004970"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116514","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of human-specific amino acid residues governing atenolol transport via organic cation transporter 2","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116514"}}